Andrew Reardon - Nov 30, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Stock symbol
LGND
Transactions as of
Nov 30, 2022
Transactions value $
-$78,222
Form type
4
Date filed
12/1/2022, 08:39 PM
Previous filing
Nov 7, 2022
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$78.2K -1.07K -8.93% $72.90 10.9K Nov 30, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Legal Officer and Secretary